5 Einträge gefunden

1. S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013

   1. Wagner, U
   2. Harter, P
   3. Hilpert, F
   4. Mahner, S
   5. Reuß, A
   6. du Bois, A
   7. Petru, E

   2013 - Forschungsinformationssystem des UKE
2. Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer

   1. Harter, P
   2. Mahner, S
   3. Hilpert, F
   4. Runnebaum, I
   5. Ortmann, O
   6. Mustea, A
   7. Sehouli, J

   2013 - Forschungsinformationssystem des UKE
3. [HER-2 and TOP2A gene amplification in urinary bladder cancer]

   1. Simon, Ronald
   2. Atefy, R
   3. Wagner, U
   4. Forster, T
   5. Fijan, A
   6. Bruderer, J
   7. Wilber, K

   2002 - Forschungsinformationssystem des UKE
4. [HER-2 and TOP 2A gene amplifications in urinary bladder carcinoma]

   1. Simon, Ronald
   2. Atefy, R
   3. Wagner, U
   4. Forster, T
   5. Fijan, A
   6. Bruderer, J
   7. Wilber, K

   2002 - Forschungsinformationssystem des UKE
5. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

   1. Simon, Ronald
   2. Richter, J
   3. Wagner, U
   4. Fijan, A
   5. Bruderer, J
   6. Schmid, U
   7. Ackermann, D

   2001 - Forschungsinformationssystem des UKE